CXI Healthcare Technology Group Limited (KOSDAQ:900120)
South Korea · Delayed Price · Currency is KRW 869.00
+4.00 (0.46%)
At close: Jul 31, 2026
KOSDAQ:900120 Ratios and Metrics
Market cap in millions KRW. Fiscal year is July - June.
Millions KRW. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 6,491 | 18,636 | 28,823 | 26,536 | 31,491 | 37,709 | |
Market Cap Growth | -71.58% | -35.34% | 8.62% | -15.73% | -16.49% | 46.59% |
Enterprise Value | -39,759 | -189,381 | -120,053 | -63,434 | -24,406 | 22,404 |
Last Close Price | 869.00 | 3100.00 | 5000.00 | 8000.00 | 12800.00 | 16150.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 3.36 | 1.46 | 0.98 | 3.53 | 5.27 | 7.40 |
Forward PE | - | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 |
PS Ratio | 0.13 | 0.32 | 0.42 | 0.37 | 0.31 | 0.36 |
PB Ratio | 0.01 | 0.04 | 0.06 | 0.06 | 0.08 | 0.10 |
P/TBV Ratio | 0.01 | 0.04 | 0.06 | 0.06 | 0.08 | 0.10 |
P/FCF Ratio | - | 0.46 | 0.66 | 0.84 | 0.88 | - |
P/OCF Ratio | 0.18 | 0.46 | 0.66 | 0.84 | 0.88 | 4.32 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | - | - | - | - | - | 0.21 |
EV/EBITDA Ratio | - | - | - | - | - | 0.97 |
EV/EBIT Ratio | - | - | - | - | - | 4.95 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.03 | 0.02 | 0.00 | 0.03 | 0.01 | 0.04 |
Debt / FCF Ratio | - | 0.02 | 0.00 | 0.03 | 0.01 | - |
Net Debt / Equity Ratio | -0.08 | -0.41 | -0.33 | -0.23 | -0.16 | -0.07 |
Net Debt / EBITDA Ratio | -1.42 | -6.03 | -3.69 | -3.01 | -2.04 | -1.07 |
Net Debt / FCF Ratio | 0.25 | -4.97 | -3.66 | -2.96 | -1.82 | 0.13 |
Asset Turnover | 0.09 | 0.12 | 0.15 | 0.17 | 0.25 | 0.28 |
Inventory Turnover | - | - | 287.20 | 163.38 | 84.46 | 48.16 |
Quick Ratio | 57.68 | 110.45 | 72.55 | 42.89 | 11.24 | 4.81 |
Current Ratio | 57.68 | 110.47 | 73.03 | 43.39 | 11.44 | 5.01 |
Return on Equity (ROE) | 1.59% | 2.62% | 6.57% | 1.81% | 1.51% | 1.40% |
Return on Assets (ROA) | 0.73% | 1.24% | 2.59% | 1.06% | 0.97% | 0.76% |
Return on Invested Capital (ROIC) | 1.20% | 2.93% | 5.83% | 2.12% | 1.80% | 1.85% |
Return on Capital Employed (ROCE) | 1.10% | 2.00% | 3.90% | 1.70% | 1.50% | 1.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 133.27% | 68.37% | 101.82% | 28.37% | 18.99% | 13.52% |
FCF Yield | -2895.83% | 215.60% | 151.50% | 119.07% | 114.25% | -520.21% |
Buyback Yield / Dilution | -59.75% | -17.38% | 79.37% | - | -10.22% | -0.77% |